1503002 Informal Interpretation
Date
Rule
Pharma license
UPDATE February 16, 2017: The original response is clarified as follows: “Based on the facts below, the Licensor will still be able to use this IP for the same indication and the same therapeutic area...
File
Original Image File
(220.62 KB)